Sec. 491.056. INVESTIGATIONAL NEW DRUG APPLICATION.
Health and Safety Code § 491.056
Version 1 of 2 published with this citation; no legal effect inferred
On the commission's notification that a consortium is selected to conduct the drug development clinical trials under this subchapter, a drug developer or hospital member of the selected consortium or the lead institution of higher education of the consortium, as specified by written agreement of the consortium members, shall, as soon as practicable:
(1) submit an investigational new drug (IND) application to the United States Food and Drug Administration in accordance with 21 C.F.R. Part 312; and
(2) seek a breakthrough therapy designation for ibogaine from the United States Food and Drug Administration under 21 U.S.C. Section 356.
Added by Acts 2025, 89th Leg., R.S., Ch. 333 (S.B. 2308), Sec. 1, eff. June 11, 2025.
Source details
- canonical id
tx-statute:hs:491.056- provision id
tx-statute:hs:[email protected]- version id
tx-statute:hs:[email protected]~33351b99f959f941- record id
tx-statute:hs:[email protected]- document id
tx-statute-chapter:hs:491- record sha256
7b687ed88cf96e664feacac3c1d40d72dc6bc48d900976ddd87d28b5364c0fab- anchor id
p-491-056-194775-201060- legalcore record url
https://legalcore.example.invalid/tx/statutes/hs/sections/491.056/194775.201060
Source locations are recorded for verification and are not links.
References in this section
-
Sec. 491.056. INVESTIGATIONAL NEW DRUG APPLICATION.
Reference details
- original href
https://statutes.capitol.texas.gov/Docs/HS/htm/HS.491.htm#491.056- target fragment
491.056- source context
paragraph- resolution reason
unique prepared provision #491.056 in tx-statute-chapter:hs:491- expected target id
tx-statute:hs:491.056- source document id
tx-statute-chapter:hs:491- source provision id
tx-statute:hs:[email protected]- target document id
tx-statute-chapter:hs:491- target provision id
tx-statute:hs:[email protected]- target version id
tx-statute:hs:[email protected]~33351b99f959f941- candidate
tx-statute:hs:[email protected]- resolution status
resolved
Source locations are recorded for verification and are not links.
-
2308
Target unavailable; not linked
Reference details
- original href
http://capitol.texas.gov/tlodocs/89R/billtext/html/SB02308F.HTM- source context
paragraph- resolution reason
target family not prepared (legislative_bill_text)- source document id
tx-statute-chapter:hs:491- source provision id
tx-statute:hs:[email protected]- resolution status
unavailable
Source locations are recorded for verification and are not links.
Cited by
-
HS § 491.056
cites it as “Sec. 491.056. INVESTIGATIONAL NEW DRUG APPLICATION.”
Reference details
- original href
https://statutes.capitol.texas.gov/Docs/HS/htm/HS.491.htm#491.056- target fragment
491.056- source context
paragraph- resolution reason
unique prepared provision #491.056 in tx-statute-chapter:hs:491- expected target id
tx-statute:hs:491.056- source document id
tx-statute-chapter:hs:491- source provision id
tx-statute:hs:[email protected]- target document id
tx-statute-chapter:hs:491- target provision id
tx-statute:hs:[email protected]- target version id
tx-statute:hs:[email protected]~33351b99f959f941- candidate
tx-statute:hs:[email protected]- resolution status
resolved
Source locations are recorded for verification and are not links.
Citations show recorded connections only, not legal effect or validity.